Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
The purpose of this study is to explore the changes in metabolic parameters in patients treated with escitalopram for six months for major depression, generalized anxiety disorder or panic disorder, with or without agoraphobia.
Generalized Anxiety Disorder
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Open-label Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months|
|Study Start Date:||September 2008|
|Study Completion Date:||October 2010|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
This is an open-label study, with 4 scheduled visits. Recruitment of 100 subjects. Assessments include demographics, diagnosis, smoking frequency, Clinical Global Scale (CGI-S), weight, height,blood pressure, waist and hip circumference and fasting blood glucose and lipd profile.
Statistical analysis will be exploratory and mainly descriptive.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00711737
|Changi General Hospital|
|Singapore, Singapore, 529889|
|Principal Investigator:||Lai H Peh, MBBS||Changi General Hospital|